01167 JACOBIO-B
- 1.690
- -0.060-3.43%
JACOBIO-B News
JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2024
JACOBIO-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
JACOBIO-B: INSIDE INFORMATION - JACOBIO ANNOUNCES EXCLUSIVE LICENSING-OUT AGREEMENT WITH ALLIST FOR GLECIRASIB AND JAB-3312
JACOBIO-B: VOLUNTARY ANNOUNCEMENT JACOBIO COMPLETED FIRST PATIENT DOSAGE IN THE PHASE III CLINICAL TRIAL OF JAB-3312 IN COMBINATION WITH GLECIRASIB
JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2024
JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2024
JACOBIO-B: NEXT DAY DISCLOSURE RETURN
JACOBIO-B: NEXT DAY DISCLOSURE RETURN
JACOBIO-B: NEXT DAY DISCLOSURE RETURN
JACOBIO-B: NEXT DAY DISCLOSURE RETURN
JACOBIO-B: NEXT DAY DISCLOSURE RETURN
JACOBIO-B: NEXT DAY DISCLOSURE RETURN
JACOBIO-B: NEXT DAY DISCLOSURE RETURN
JACOBIO-B: NEXT DAY DISCLOSURE RETURN
JACOBIO-B: NEXT DAY DISCLOSURE RETURN
JACOBIO-B: NEXT DAY DISCLOSURE RETURN
JACOBIO-B: NEXT DAY DISCLOSURE RETURN
JACOBIO-B: VOLUNTARY ANNOUNCEMENT INTENTION TO CONDUCT ON-MARKET SHARE REPURCHASE
JACOBIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2024
JACOBIO-B: VOLUNTARY ANNOUNCEMENTJACOBIO PRESENTED TWO CLINICAL DATA AT THE 2024 ASCO
Analysis
Price Target
No Data
No Data